UNSPSC 85812413: Introduction of oxazolidinones into mouth and pharynx, via natural or artificial opening

This classification denotes the group of activities that yields a administrative intervention or procedure to introduction of oxazolidinones into mouth and pharynx, via natural or artificial opening. This administrative intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 3E0D728

UNSPSC 85812413 Introduction of oxazolidinones into mouth and pharynx, via natural or artificial opening is a Commodity code representing a narrowly defined pharmaceutical administration pathway. The code shows minimal alignment with actual state and local procurement activity. Recent opportunities posted under or near this code span telehealth urgent care, comprehensive occupational health services, cancer registry operations, PACE program management, opioid use disorder treatment and recovery, emergency medical services staffing, employee wellness platforms, and behavioral health crisis services — none of which match the code's stated scope of oxazolidinone drug administration. The issuing bodies span state health departments, counties, cities, health authorities, school districts, and special-purpose health districts across California, Nevada, Georgia, Colorado, Texas, Kansas, Florida, Missouri, and the District of Columbia, with no concentration in any single jurisdiction or entity type.

The mismatch between the code's nominal scope and recent posted opportunities suggests the code is either misapplied in state and local procurement systems or sees negligible legitimate activity under its intended definition. If your firm pursues pharmaceutical supply or medication administration services, verify the correct UNSPSC classification with issuing procurement offices before investing in proposals; the opportunities visible under this code do not reflect pharmaceutical commodity procurement and do not represent a tractable market segment. The code merits skip status unless your research identifies a distinct population of issuers consistently tagging medication-delivery contracts with this code.